Skip to content

21 U.S.C. § 360aa

Title 21 Chapter 9 Current through PL 116-220 ~1 min read Last updated: March 30, 2026 View on OLRC →
Sections in this chapter

§ 360aa. Recommendations for investigations of drugs for rare diseases or conditions

  • (a) The sponsor of a drug for a disease or condition which is rare in the States may request the Secretary to provide written recommendations for the non-clinical and clinical investigations which must be conducted with the drug before—
    • (1) it may be approved for such disease or condition under section 355 of this title , or
    • (2) if the drug is a biological product, it may be licensed for such disease or condition under section 262 of title 42 .
  • (b) The Secretary shall by regulation promulgate procedures for the implementation of subsection (a).

Change History

No amendments tracked yet for this section.

Change history will appear here automatically when the pipeline detects modifications between US Code release points.